BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 25, 2011
View Archived Issues
Novel orexin receptor antagonists described by Merck & Co.
Read More
New free fatty acid FFA1 receptor agonists disclosed
Read More
Phase IIa study shows no appreciable difference between SYN-118 and placebo in Parkinson's disease
Read More
Genasense does not improve survival of dacarbazine-treated patients with melanoma in phase III trial
Read More
SLC23A1 gene SNP correlates with neovascular age-related macular degeneration
Read More
AZD-3199 has long-lasting bronchoprotective activity in vivo
Read More
Scientists identify alpha-1-antitrypsin as marker of cutaneous squamous cell carcinoma progression
Read More
Gene therapy JVS-100 is safe in patients with heart failure after myocardial infarction
Read More
Pfizer designs new sodium/glucose cotransporter 2 inhibitors
Read More
Anavex advances Alzheimer's disease candidate ANAVEX 2-73 to higher dose in phase I trial
Read More
Lilly forms new critical care company BioCritica
Read More
Mutations in CACNA2D1 gene may confer susceptibility to Brugada syndrome
Read More
Provectus Pharmaceuticals completes accrual in phase IIc PH-10 trial in psoriasis
Read More
Ampio Pharmaceuticals completes evaluation of phase III data on Zertane
Read More
Merck & Co. presents new NO-linked cicletanine and derivatives
Read More
NovaBay's NVC-422 shows promise in patients with epidemic keratoconjunctivitis
Read More
Novel erythropoietin production enhancers presented by Daiichi Sankyo
Read More
Prometheus to be acquired by Nestle Health Science
Read More
Preclinical study of Proteonomix's UMK-121 suggests ability to mobilize stromal stem cells
Read More
Toxicology studies completed for Alzheimer's disease drug candidate SUVN-502
Read More
FDA sets PDUFA date for fentanyl sublingual spray NDA review
Read More
FDA advisory committee to discuss Regeneron's BLA for VEGF Trap-Eye in June
Read More
Basilea Pharmaceutica reports topline data from first phase I trial of BAL-30072
Read More
Eisai and University College London to conduct joint research in neurodegenerative disease
Read More
CHMP issues negative trend vote on Bronchitol for cystic fibrosis
Read More